Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 22, 1996Science

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMichael HahneCentre National de la Recherche ScientifiqueDRDonata RimoldiUniversity of GenevaMSMichael SchröterUniversity Hospital Cologne

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hahne et al. (1996) studied this question.

synapsesocial.com/papers/6a11cbd4ed9c06332dfd39cehttps://doi.org/10.1126/science.274.5291.1363
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes1996 · 62 citations
  2. 2Tumor Antigens Recognized by T Lymphocytes1994 · 1,230 citations
  3. 3Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.1987 · 491 citations
  4. 4Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.1996 · 457 citations